Researchers reported Thursday that they have created a new model for studying treatments of Alzheimer’s disease — in rhesus macaque monkeys — that may speed the search for therapies that make an appreciable difference in the course of an illness that affects nearly 6 million Americans.
Despite three decades of intensive research on Alzheimer’s, and billions of dollars in funding, researchers have yet to find a way to prevent or cure, or even to slow, the disease as it rampages through aging brains. Some blame the mice.
What is it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Discussion about this post